“Spesolimab Use for Generalized Pustular Psoriasis Flare Prevention in Patients with Concomitant Plaque Psoriasis: Results from the Effisayil 2 Trial”, J of Skin, vol. 8, no. 2, p. s360, Mar. 2024, doi: 10.25251/skin.8.supp.360.